MeiraGTx Holdings plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
MeiraGTx Holdings plc (MGTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 312.71 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-13
- MeiraGTx Holdings plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 214.64K shares, a 20.04% increase year-over-year.
- MeiraGTx Holdings plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 98.07K shares, a 53.07% decline year-over-year.
- MeiraGTx Holdings plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 75.21K shares, a 84.86% increase year-over-year.
- MeiraGTx Holdings plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 94.04K shares, a 46.69% increase year-over-year.
- MeiraGTx Holdings plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 557.01K shares, a 55.06% increase from fiscal 2024.
- MeiraGTx Holdings plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 359.22K shares, a 105.65% increase from fiscal 2023.
- MeiraGTx Holdings plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 174.68K shares, a 67.14% decline from fiscal 2022.
- MeiraGTx Holdings plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 531.60K shares, a 39.48% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 214.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 312.71K shares 10-Q · filed 2026-08-13 | 387.92K shares derived: sum of 3 quarters · filed 2026-08-13 | 481.96K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 98.07K shares 10-Q · filed 2026-05-14 | 173.28K shares derived: sum of 2 quarters · filed 2026-05-14 | 267.32K shares derived: sum of 3 quarters · filed 2026-05-14 | 446.13K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 75.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 169.25K shares derived: sum of 2 quarters · filed 2026-03-30 | 348.06K shares derived: sum of 3 quarters · filed 2026-03-30 | 557.01K shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 94.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 272.85K shares derived: sum of 2 quarters · filed 2025-11-13 | 481.81K shares 10-Q · filed 2025-11-13 | 522.49K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 178.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 387.77K shares 10-Q · filed 2025-08-14 | 428.45K shares derived: sum of 3 quarters · filed 2025-08-14 | 492.56K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 208.96K shares 10-Q · filed 2025-05-13 | 249.64K shares derived: sum of 2 quarters · filed 2025-05-13 | 313.75K shares derived: sum of 3 quarters · filed 2025-05-13 | 461.02K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 40.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 104.79K shares derived: sum of 2 quarters · filed 2025-03-13 | 252.06K shares derived: sum of 3 quarters · filed 2025-03-13 | 359.22K shares 10-K · filed 2025-03-13 |
| 2024-09-30 | 64.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 211.37K shares derived: sum of 2 quarters · filed 2024-11-13 | 318.54K shares 10-Q · filed 2024-11-13 | 350.64K shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 147.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 254.43K shares 10-Q · filed 2024-08-12 | 286.53K shares derived: sum of 3 quarters · filed 2024-08-12 | 331.23K shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 107.16K shares 10-Q · filed 2024-05-09 | 139.26K shares derived: sum of 2 quarters · filed 2024-05-09 | 183.97K shares derived: sum of 3 quarters · filed 2024-05-09 | 233.47K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 32.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 76.80K shares derived: sum of 2 quarters · filed 2024-03-15 | 126.31K shares derived: sum of 3 quarters · filed 2024-03-15 | 174.68K shares 10-K · filed 2024-03-15 |
| 2023-09-30 | 44.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 94.21K shares derived: sum of 2 quarters · filed 2023-11-14 | 142.58K shares 10-Q · filed 2023-11-14 | 292.33K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 49.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 97.87K shares 10-Q · filed 2023-08-10 | 247.63K shares derived: sum of 3 quarters · filed 2023-08-10 | 337.68K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 48.37K shares 10-Q · filed 2023-05-11 | 198.13K shares derived: sum of 2 quarters · filed 2023-05-11 | 288.18K shares derived: sum of 3 quarters · filed 2023-05-11 | 487.28K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 149.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 239.81K shares derived: sum of 2 quarters · filed 2023-03-14 | 438.91K shares derived: sum of 3 quarters · filed 2023-03-14 | 531.60K shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 90.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 289.16K shares derived: sum of 2 quarters · filed 2022-11-10 | 381.84K shares 10-Q · filed 2022-11-10 | 601.29K shares derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-06-30 | 199.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 291.79K shares 10-Q · filed 2022-08-11 | 511.23K shares derived: sum of 3 quarters · filed 2023-03-14 | 583.61K shares derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-03-31 | 92.69K shares 10-Q · filed 2022-05-12 | 312.13K shares derived: sum of 2 quarters · filed 2023-03-14 | 384.50K shares derived: sum of 3 quarters · filed 2023-03-14 | 407.88K shares derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-12-31 | 219.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 291.81K shares derived: sum of 2 quarters · filed 2023-03-14 | 315.19K shares derived: sum of 3 quarters · filed 2023-03-14 | 381.14K shares 10-K · filed 2023-03-14 |
| 2021-09-30 | 72.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 95.75K shares derived: sum of 2 quarters · filed 2021-11-10 | 161.70K shares 10-Q · filed 2021-11-10 | 291.47K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2021-06-30 | 23.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 89.33K shares 10-Q · filed 2021-08-11 | 219.10K shares derived: sum of 3 quarters · filed 2022-03-10 | 385.89K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2021-03-31 | 65.96K shares 10-Q · filed 2021-05-11 | 195.73K shares derived: sum of 2 quarters · filed 2022-03-10 | 362.52K shares derived: sum of 3 quarters · filed 2022-03-10 | 393.75K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-12-31 | 129.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 296.56K shares derived: sum of 2 quarters · filed 2022-03-10 | 327.79K shares derived: sum of 3 quarters · filed 2022-03-10 | 377.79K shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 166.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 198.02K shares derived: sum of 2 quarters · filed 2020-11-05 | 248.02K shares 10-Q · filed 2020-11-05 | 252.17K shares derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-06-30 | 31.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 81.23K shares 10-Q · filed 2020-08-06 | 85.38K shares derived: sum of 3 quarters · filed 2021-03-11 | 95.38K shares derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-03-31 | 50.00K shares 10-Q · filed 2020-05-07 | 54.15K shares derived: sum of 2 quarters · filed 2021-03-11 | 64.15K shares derived: sum of 3 quarters · filed 2021-03-11 | 75.47K shares derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-12-31 | 4.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 14.15K shares derived: sum of 2 quarters · filed 2021-03-11 | 25.47K shares derived: sum of 3 quarters · filed 2021-03-11 | 25.47K shares 10-K · filed 2021-03-11 |
| 2019-09-30 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 21.32K shares derived: sum of 2 quarters · filed 2019-11-07 | 21.32K shares 10-Q · filed 2019-11-07 | 27.24K shares derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-06-30 | 11.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 11.32K shares 10-Q · filed 2019-08-07 | 17.24K shares derived: sum of 3 quarters · filed 2020-03-11 | 21.88K shares derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-14 | 5.92K shares derived: sum of 2 quarters · filed 2020-03-11 | 10.56K shares derived: sum of 3 quarters · filed 2020-03-11 | |
| 2018-12-31 | 5.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | 10.56K shares derived: sum of 2 quarters · filed 2020-03-11 | 10.56K shares 10-K · filed 2020-03-11 | |
| 2018-09-30 | 4.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 4.63K shares 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-08 | |||
| 2017-12-31 | 5.67K shares 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |